Veracyte | 销售成本

股票价格

35.09

每天变化

-0.92 -2.55%

每月一次

-2.80%

每年

2.87%

Q1 预测

35.47

金融业

USD

USD 1.41B

现金及等价物

USD 362.58M

USD 39.29M

USD 488.38M

USD 59.94M

USD 40.45M

USD 24.63M

USD 42.31M

824

EPS每股收益

USD 0.53

股本和储备

USD 1.26B

USD 101.97M

债务利息支出

USD 2K

USD 3.48M

USD 0

USD 2.82B

USD 41.15M

USD 116.01M

USD 24.63M

普通股股本

USD 79.05M

USD 45.3

USD 40.63M

USD 140.6M

销售和管理费用

USD 43.31M

USD 20.55M

贸易债权人

USD 4.59M

应收帐款人

USD 44.66M

	销售成本	更改		日
Agenus	USD 137K		19K	2025-03
Agilent	USD 852M		19M	2025-12
Anika Therapeutics	USD 11.49M		35.48M	2025-03
Bruker	USD 528M		46.9M	2025-12
Exact Sciences	USD 266.81M		18.18M	2025-09
Heron Therapeutics	USD 9.46M		1.61M	2024-09
Illumina	USD 400M		49M	2025-12
Intrexon	USD 1.01M		344K	2024-06
Karyopharm Therapeutics	USD 37.43M		2.41M	2024-09
Laboratory Of America	USD 2.6B		56.8M	2025-12
Ligand Pharmaceuticals	USD 11.9M		733K	2025-09
Myriad Genetics	USD 61.9M		600K	2025-09
Rigel Pharmaceuticals	USD 8.03M		5.22M	2024-09
Roche Holding	CHF 8.48B		4.61B	2025-12
Sangamo BioSciences	2.42M		1.11M	2024-06
Siemens	EUR 11.51B		1.82B	2025-12
Sonic Healthcare	AUD 751.66M		801.13M	2024-12
Thermo Fisher Scientific	USD 7.58B		674M	2025-12
Veracyte	USD 39.28M		1.93M	2025-12
Waters	USD 374.94M		47.13M	2025-12

Veracyte 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.